Unifirst Corp: Form 10-Q for the period ended May 31, 2025
Filed with the SEC on Jul 9, 2025 and accepted by EDGAR at Jul 9, 2025, 17:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-05-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-03-02 to 2025-05-31 | $610.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-09-01 to 2025-05-31 | $1.82bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-03-02 to 2025-05-31 | $385.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2024-09-01 to 2025-05-31 | $1.16bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2025-03-02 to 2025-05-31 | $142.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-09-01 to 2025-05-31 | $418.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-03-02 to 2025-05-31 | $48.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-09-01 to 2025-05-31 | $134.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-03-02 to 2025-05-31 | $13.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-09-01 to 2025-05-31 | $36.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-03-02 to 2025-05-31 | $39.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-09-01 to 2025-05-31 | $107.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-03-02 to 2025-05-31 | $2.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-09-01 to 2025-05-31 | $5.76 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2025-03-02 to 2025-05-31 | 18,607,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-09-01 to 2025-05-31 | 18,633,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-09-01 to 2025-05-31 | $196.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-09-01 to 2025-05-31 | $109.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-09-01 to 2025-05-31 | $18.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2024-09-01 to 2025-05-31 | $25.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-05-31 | $211.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-05-31 | $937.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-05-31 | $2.76bn | us-gaap:Assets |
| Current liabilities | At period end2025-05-31 | $266.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-05-31 | $585.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-05-31 | $2.17bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-094853. Last ingested by Listed: Nov 3, 2026, 21:35 ET. Listed shows no prices and gives no investment advice.